# FDA Inspection 902219 - Innovative Blood Resources - October 21, 2014

Source: https://www.keypedia.com/records/fda_inspections/innovative-blood-resources/7d8b9fca-6093-4df7-bd87-78d409e800e2
Source feed: FDA_Inspections

> FDA Inspection 902219 for Innovative Blood Resources on October 21, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 902219
- Company Name: Innovative Blood Resources
- Inspection Date: 2014-10-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1194208 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/innovative-blood-resources/f47a0c27-e04d-4bbb-9cd1-46d0215724c7)
- [FDA Inspection 1194208 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/innovative-blood-resources/1da56062-5233-4a59-92df-a8541730d54d)
- [FDA Inspection 1099476 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/innovative-blood-resources/96b7d9e5-4065-4a16-974e-04dced4f8ebe)
- [FDA Inspection 990229 - 2016-10-06](https://www.keypedia.com/records/fda_inspections/innovative-blood-resources/9f678f25-c605-4216-ad1c-b5939ddc384a)
- [FDA Inspection 852967 - 2013-10-16](https://www.keypedia.com/records/fda_inspections/innovative-blood-resources/07c3764f-1a2e-4208-845a-73f69da1749e)

Company: https://www.keypedia.com/companies/innovative-blood-resources/44bc20e8-cfc2-4fd5-afce-d139817e64bd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d